Experimental HIV Therapy Shot Could Replace Daily Pill (1)

HIV patients could replace their daily pills with a monthly shot under an experimental medication now being tested by NIH scientists with the help of Johnson & Johnson’s research arm, Janssen Pharmaceutical Cos.

If successfully brought onto the market, these injections could be instrumental in meeting the White House’s goal to end the AIDS epidemic in the U.S. within the next decade by making the treatment plan less cumbersome.

HIV treatments, which are also known as antiretroviral therapy, or ART, have successfully helped HIV patients live longer, healthier lives while reducing the risk of transmission. Taking the treatments as ...